Literature DB >> 415005

Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

J Greenblatt, R J Boackle, J H Schwab.   

Abstract

Activation of the alternate complement pathway in human serum by several bacterial components was compared. Peptidoglycan from group A streptococcal cell walls was the most active material, on a weight basis, followed by cell walls, protoplast membranes, and whole cells. The group-specific carbohydrate was inactive. Treatment of peptidoglycan with low concentrations of lysozyme or short periods of sonic treatment enhanced complement activation. High concentrations of lysozyme or extended sonic treatment of peptidoglycan destroyed or greatly reduced the capacity to activate complement. Lysozyme treatment of group A streptococcal cell walls or lipopolysaccharide had no measurable effect. Activation of the alternate complement pathway by group D streptococcal cell walls was destroyed by lysozyme. Activity of peptidoglycan was not inhibited by N-acetyl glucosamine, N-acetyl muramic acid, or D-alanine-D-alanine. Conversion of C3 and factored B by peptidoglycan was shown to occur by immunoelectrophoresis and crossed immunoelectrophoresis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415005      PMCID: PMC414080          DOI: 10.1128/iai.19.1.296-303.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Activation of the alternative pathway by pneumococcal cell walls.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

2.  Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.

Authors:  R K Dhingra; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

3.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

4.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

5.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

6.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

7.  Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.

Authors:  J W Tauber; M J Polley; J B Zabriskie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

8.  Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci.

Authors:  R M KRAUSE; M MCCARTY
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

9.  Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.

Authors:  R D Schreiber; O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  46 in total

1.  Alternate complement pathway activation by group A streptococci: role of M-protein.

Authors:  A L Bisno
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

2.  Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.

Authors:  R A Eisenberg; J H Schwab
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

3.  Opsonized streptococcal cell walls cross-link human leukocytes and erythrocytes by complement receptors.

Authors:  K B Pryzwansky; J D Lambris; E K MacRae; J H Schwab
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

4.  Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls.

Authors:  A Fox; R R Brown; S K Anderle; C Chetty; W J Cromartie; H Gooder; J H Schwab
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Relationship of complement to experimental arthritis induced in rats with streptococcal cell walls.

Authors:  J H Schwab; J B Allen; S K Anderle; F Dalldorf; R Eisenberg; W J Cromartie
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

6.  Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus.

Authors:  N Okada; M K Liszewski; J P Atkinson; M Caparon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Activation of the alternative complement pathway by L-phase variants of gram-positive bacteria.

Authors:  F T Saulsbury; J A Winkelstein
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes.

Authors:  P A Leong; M S Cohen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: implications for pathogenesis of chronic inflammation.

Authors:  P A Leong; J H Schwab; M S Cohen
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

Review 10.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.